분자-학술대회내지

Transcription

1 Abstract submission: July 18 - September 15 Early registration: July 18 - September 15 URL: October 6-7, 2011 COEX, Seoul, Korea Seminar: Conference Center (3F) Grand Conference Room (4F) Exhibition & Poster Presentation: Hall C1-C2 (3F) 한국분자 세포생물학회 Sponsored by Korean Federation of Science and Technology Societies

2 Abstract submission: July 18 - September 15 Early registration: July 18 - September 15 URL: October 6-7, 2011 COEX, Seoul, Korea Seminar: Conference Center (3F) Grand Conference Room (4F) Exhibition & Poster Presentation: Hall C1-C2 (3F) 한국분자 세포생물학회

3 2011 년한국분자 세포생물학회운영위원및대의원명단 KSMCB Organizing Committee

4 2011 년한국분자 세포생물학회정기학술대회 The 23 rd Annual Meeting of the Korean Society for Molecular and Cellular Biology

5

6

7 Dear Colleagues, The 2011 Annual Meeting of the Korean Society for Molecular and Celluar Biology (KSMCB), the biggest event in the bioscience community in the Republic of Korea, will be held at the COEX in Seoul, for two days from October 6 through 7, The development of bioscience requires us to learn new knowledge and share results restlessly. Our annual meeting have played a key role by providing opportunities to present, discuss and exchange the latest results and information and thus contribute to improve the level of Korean bioscience. At the forthcoming conference, Dr. John Blenis (Harvard Medical School, USA), Dr. Paul B. Fisher (Virginia Commonwealth University, USA), Dr. Wendell A. Lim (University of California San Francisco, USA), Dr. Eric N. Olson (University of Texas Southwestern Medical Center at Dallas, USA) will deliver speeches as key-note speakers and more than 170 of domestic and foreign experts will release their recent results in the symposia on 23 themes throughout bioscience. In particular, a symposium on research ethics will be held, which is a unique case in the academic conferences of bioscience-related societies in the Republic of Korea. There will be also an awarding ceremony for the Academic Research Award and Molecules and Cells Award of KSMCB, the Macrogen Scientist Award, the Ilchun Memorial Lecture, the Bioneer Next Generation Research Award, the Excellent Doctoral Thesis Award, and the Excellent Poster Award, etc. In addition, companies and industries in the field of bioscience will participate in exhibition, providing you with the recent information on research materials, tools and equipments. I hope you would attend this conference actively, thus enjoy this opportunity by exchanging the up-todate research information. I hope this conference would be a fruitful and memorable one to you. I would like to take this oppontunity to express my heartfelt thanks to all the members of Academic Program Committee and Symposium Organizers as well as the Korean Federation of Science and Technology Societies (KOFST) and participating companies for the finalcial support. Sincerely yours, Yang Do Choi, Ph.D. President of the Korean Society for Molecular and Cellular Biology

8 안 내 General Information

9 Time Table of the 23 rd Annual Meeting of the KSMCB Thursday, October 6, 2011 Place Time 08:00-09:00 09:00-11:30 11:30-12:20 12:20-13:20 13:20-14:00 14:00-14:40 14:40-15:20 15:20-15:30 15:30-18:00 Room 401 SY01 Cell Cycle& Chromosome Dynamics and Genetic Instability Room 402 Room 307 Room 308 Room 317 Room 318 SY02 RNA-Expression and Function Registration SY03 Light Signaling and Flowering Council Meeting Research Ethics Sym. Workshop 1 Workshop 2 Workshop 3 Break & Poster Viewing Academic Research Awards Lecture (Rm. 401) Plenary Lectures PL 1. John Blenis (Harvard Medical School, USA) (Rm. 401) PL 2. Paul B. Fisher (Virginia Commonwealth Univ., USA) SY07 Redox Modulation of Pro- Inflammatory and Anti-inflammatory Signaling Break SY08 Cancer Biology SY04 Neurobiological Basis of Behaviors SY09 Bio-Molecular Imaging SY05 A Multidisciplinary Approach to the Study of the Functionality and Mechanism of Protein- DNA Interactions SY10 O-GlcNAc Biology SY06 Signal Network in Disease SY11 Presynaptic Vesicular Traffickings Hall C1- C2 (3F) Poster/Exhibition Poster Presentation 09:20-18:00 (Duty: 12:20-13:20) 18:00-19:00 Korean Reception (Rm. 402) Friday, October 7, 2011 Place Time 08:00-09:00 09:00-11:30 11:30-12:00 12:00-12:50 12:50-13:30 13:30-14:00 14:00-14:40 14:40-15:20 15:20-15:30 15:30-18:00 18:00-18:30 Korean Room 401 Room 402 Room 307 Room 308 Room 317 Room 318 Registration SY12 SY13 SY14 SY15 SY16 SY17 Chromatin Remodeling and Gene Expression Mouse Phenogenomics Molecular and Cellular Mechanisms of Plant Development Bioactive Lipid Signaling in Cancer and Criminal DNA Database and Forensic Genetics Structural Biology of Post-Translational Modification Proteins Plasticity Inflammation Macrogen Scientist Award (Rm. 401) KSMCB GA Women s Bioscience Forum Workshop 4 Workshop 5 Workshop 6 Workshop 7 Break & Poster Viewing Ilchun Memorial Lecture (Rm. 401) Plenary Lectures (Rm. 401) SY18 Autophagy SY19 Stem Cells: Biology and Therapeutic Applications PL 3. Wendell A. Lim (Univ. of California San Francisco, USA) PL 4. Eric N. Olson (Univ. of Texas Southwestern Medical Center at Dallas, USA) Break SY20 Systems Biology for Plants SY21 The Advancement of Innate Immunity: Pattern-Recognition Receptors and Their Actions Excellent Poster Awards & Closing Remark (Rm. 401) SY22 Bone and Cartilage Biology SY23 Convergence Sciences and Mucosal Immune System Hall C1- C2 (3F) Poster/Exhibition Poster Presentation 09:20-18:00 (Duty: 12:50-13:30)

10 학술대회장안내 Venue Guide 3F Conference Center 3F 4F Grand Conference Room

11 Plenary Lecture Plenary Lecture 14:00-14:40, Thursday, October 6, 2011 (Grand Conference Room 401) Organizer & Chair : Jongkyeong Chung, Ph.D. (School of Biological Sciences, Seoul National University, Korea) John Blenis, Ph.D., is in the Department of Cell Biology at Harvard Medical School since He was promoted to Professor in 1996 and became a member of the WCI-KRIBB program in Prior to joining Harvard Medical School, Dr. Blenis trained in the laboratory of Professor Raymond L. Erikson at Harvard University. The Blenis laboratory utilizes molecular, cell biological and biochemical approaches to understand how altered cellular signaling and metabolism contributes to the tumor cell phenotype. Current efforts are designed to understand how PI3- kinase, Ras and mtor signal transduction systems are regulated and affect normal and disease-related modulation of cellular metabolism, protein synthesis, cell survival and cell death, migration and invasion, and cell growth and proliferation. Ultimately, this knowledge will be used to identify pathway specific small molecule inhibitors, develop biomarker assays for disease detection, and produce strategies for personalized therapeutic approaches. Dr. Blenis is a leader in defining how Ras and PI3-kinase proto-oncoproteins regulate cellular signaling in normal and cancer cells. Dr. Blenis was among the first to demonstrate that Ras mediated signaling from tyrosine kinases to the serine/threonine kinases Raf, ERK and RSK. He showed that activated ERK and RSK rapidly accumulate in the nucleus, revealing how cell surface signals reach the nucleus to alter gene expression. He then demonstrated how several induced gene products act as molecular sensors converting subtle differences in ERK and RSK signals into specific biological responses. In parallel studies, Dr. Blenis discovered that S6 kinase acts downstream of phosphatidylinositols modified by PI3-kinase. He also found that S6 kinase activation is inhibited by the natural product rapamycin, now in clinical trials for various cancers. These data established links between PI3-kinase, mtor and S6 kinase, and Dr. Blenis is a leader in defining this complex signaling system. Recently, Dr. Blenis illuminated complex mechanisms by which mtor and S6 kinase regulate protein synthesis and cell growth. Many of these pathway components are now targets for drug development. Dr. Blenis has published over 140 peer-reviewed articles and is the recipient of several awards including Research Award from the American Cancer Society, Established Investigator Award from the American Heart Association, John A. Boezi Memorial Alumnus Award from Michigan State University, the NIH/NCI MERIT award for his work on cellular transformation by the Ras-ERK/MAP kinase pathway, and the LAM Foundation Established Investigator Award.

12 Plenary Lecture Plenary Lecture 14:40-15:20, Thursday, October 6, 2011 (Grand Conference Room 401) Organizer & Chair : Dongchul Kang, Ph.D. (Ilsong Institute of Life Science, Hallym University, Korea) Paul B. Fisher, M.Ph., Ph.D., is Professor and Chair of the Department of Human & Molecular Genetics, Founding Director, VCU Institute of Molecular Medicine and holder of the Thelma Newmeyer Corman Chair in Cancer Research in the VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, Virginia. Prior to this position he was Professor of Clinical Pathology, Director of Neuro-Oncology Research and the Michael and Stella Chernow Urological Cancer Research Scientist in Columbia University, College of Physicians and Surgeons in New York. Dr. Fisher s research focuses on comprehending the molecular and biochemical basis of cancer progression to metastasis and defining improved methods for cancer detection, chemoprevention and therapy. His research also addresses mechanisms of neurodegeneration and infectious diseases. Dr. Fisher pioneered subtraction hybridization in the 1990 s to identify and clone novel genes involved in important physiological processes. Using this approach his research group was the first to clone: the cyclin-dependent kinase inhibitor p21 as melanoma differentiation-associated gene-6 (mda-6); the novel IL-10 gene family member mda-7/il-24 that selectively induces apoptosis or toxic autophagy uniquely in multiple cancers without affecting normal cells; mda-5, a patent receptor for double-stranded RNA that is a key component of the innate immune process; human polynucleotide phosphorylase, a RNA degrading enzyme targeting specific RNAs such as c-myc for destruction and induces cellular senescence; astrocyte elevated gene-1 (AEG-1) a unique gene that is upregulated in multiple cancers (including those of brain, breast, esophagus, prostate and liver) and is a potential therapeutic target; and genes upregulated or downregulated during cancer progression. One initially novel gene of particular importance cloned by this approach, mda-7/il-24 has been tested in vivo in patients and been found to be safe and display significant clinical activity when administered intratumorally in diverse advanced cancers. His laboratory has isolated several novel gene promoters, including progression elevated gene- 3 promoter (PEG-Prom), and demonstrated expression at elevated levels in virtually all cancers of both rodent and human origins. The PEG-Prom was used to create therapeutic viruses that replicate only in cancer cells and produce mda-7/il-24 (Cancer Terminator Virus) and to image primary tumors and metastases in vivo in animals. The PEG-Prom is also being used as a small molecule-screening platform to identify molecular probes for interrogating known and novel targets mediating cellular transformation, tumorigenesis and metastasis. Dr. Fisher is among the unique top 5% of NIH funded investigators over the past 30 years. He is currently PI on a multi-institutional program project grant, three R01 grants, an IRACDA grant, an R03 grant and private foundation grants from the National Foundation for Cancer Research and the Samuel Waxman Cancer Research Foundation. Dr. Fisher has published over 400 primary papers and reviews including articles in Cell, Science and Nature, served on numerous NIH study sections and government and private grant review panels, and has over 50 issued patents. He is on 18 Editorial Boards including Cancer Research (Breaking Advances Editor), Molecular Therapy, and Cancer Biology & Therapy and is Co-Editor in Chief of Advances in Cancer Research. He was the founder of GenQuest a functional genomics company that merged with Corixa Corporation was traded on NASDAQ and was acquired by Glaxo-SmithKline.

13 Plenary Lecture Plenary Lecture 14:00-14:40, Friday, October 7, 2011 (Grand Conference Room 401) Organizer & Chair : Sang-Hyun Park, Ph.D. (Department of Biological Sciences, Seoul National University, Korea) Dr. Wendell Lim is Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco and an investigator of the Howard Hughes Medical Institute. He received his A.B. in chemistry from Harvard University and his Ph.D. in biochemistry and biophysics from the Massachusetts Institute of Technology. He a pioneer in the field of Synthetic Biology, where scientists create new or precisely modified systems by rearranging biological components. Dr. Lim believes that cell systems rely on modules, the biological equivalent of electronic components. One way to understand how natural systems work is to take these components apart, rearranging, rewiring, and soldering them into nonnatural ± circuits. It s a way of letting the organism tell you what s important in order to be able to perform a certain function, Dr. Lim says. In numerous landmark papers published in Science, Nature and Cell, he has shown that cell signaling pathways are actually built from modular components which can be artificially rewired to reprogram signaling systems. These biological modules are reused in different cells and organisms to accomplish various tasks. An example of one such module is a scaffold protein that can simultaneously bind to many other proteins. Dr. Lim describes these molecules as the wiring that promotes efficient communication with the right partners and prevents crosstalk with the wrong ones. But little is known about these critical nodes, he notes, so his lab is trying to figure out how they direct the flow of information. One way to tease out the contributions of each of biology s modular components, he says, is to build cell signaling systems from scratch. Dr. Lim believes that by linking these components into functional systems, this noble engineering approach offers a way to understand how the pieces fit and functions together. Currently, he is Director of the NIH Nanomedicine Development Center and Deputy Director of the National Science Foundation Synthetic Biology Engineering Research Center.

14 Plenary Lecture Plenary Lecture 14:40-15:20, Firday, October 7, 2011 (Grand Conference Room 401) Organizer & Chair : Sung Soo Kim, M.D., Ph.D. (Kyung Hee University School of Medicine, Korea) Eric Olson has dedicated his career to deciphering the mechanisms that control muscle gene regulation and development. His most recent work has focused on the genetic pathways responsible for congenital and acquired cardiovascular disease. Dr. Olson grew up in North Carolina where he attended Wake Forest University and received a B.A. in Chemistry and Biology in 1977, a Ph.D. in Biochemistry in 1981 and an honorary doctorate in After postdoctoral training with Luis Glaser at Washington University School of Medicine, he joined the Department of Biochemistry and Molecular Biology at The M. D. Anderson Cancer Center in 1984 and became Professor and Chairman in In 1995, he founded the Department of Molecular Biology at The University of Texas Southwestern Medical Center at Dallas. Dr. Olson s honors include the Basic Research Prize, the Founding Distinguished Scientist Award, and the Research Achievement Award from the American Heart Association, the Pasarow Medical Research Award in Cardiovascular Disease, the Gill Heart Institute Award, the Lucian Award for Research in Cardiovascular Disease, the Outstanding Investigator Award from the International Society for Heart Research, and the Pollin Prize for Lifetime Contributions to Pediatric Research. In 2009, the Institut de France and French Academy of Science awarded Dr. Olson the Fondation Lefoulon-Delalande Grand Prize, considered the largest international award in cardiovascular medicine. He is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and its Institute of Medicine. In his spare time, Eric Olson plays guitar and harmonica with The Transactivators, a rock band inspired by the Texas icon, Willie Nelson, who created the Professorship that Olson holds.

15 Symposia Symposium 1 Cell Cycle & Chromosome Dynamics and Genetic Instability 09:00-11:20, Thursday, October 6, 2011 (Grand Conference Room 401) Organizer & Chair: Chang-Woo Lee, Ph.D. (Sungkyunkwan Universiry School of Medicine, Korea) SY01-1 SY01-2 SY01-3 SY01-4 SY01-5

16 Symposium 2 RNA-Expression and Function 09:00-11:30, Thursday, October 6, 2011 (Grand Conference Room 402) Organizers & Chairs: Sunjoo Jeong, Ph.D. (Department of Molecular Biology, Brain Korea 21 Graduate Program for RNA Biology, Dankook University, Korea) Haihong Shen, Ph.D. (School of Life Sciences, Gwangju Institute of Science and Technology, Korea) SY02-1 SY02-2 SY02-3 SY02-4 SY02-5 SY02-6 SY02-7 SY02-8

17 Symposium 3 Light Signaling and Flowering 09:00-11:30, Thursday, October 6, 2011 (Hall 307) Organizer & Chair: Giltsu Choi, Ph.D. (Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Korea) SY03-1 SY03-2 SY03-3 SY03-4 SY03-5 SY03-6

18 Symposium 4 Neurobiological Basis of Behaviors 09:00-11:30, Thursday, October 6, 2011 (Hall 308) Organizer & Chair: Ja-Hyun Baik, Ph.D. (Molecular Neurobiology Laboratory, College of Life Sciences and Biotechnology, Korea University, Korea) SY04-1 SY04-2 SY04-3 SY04-4 SY04-5

19 A Multidisciplinary Approach to the Study of the Functionality and Symposium 5 Mechanism of Protein-DNA Interactions 09:00-11:30, Thursday, October 6, 2011 (Hall 317) Organizer & Chair: Kyeong Kyu Kim, Ph.D. (Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Korea) SY05-1 SY05-2 SY05-3 SY05-4 SY05-5 SY05-6 SY05-7

20 Symposium 6 Signal Network in Disease 09:00-11:30, Thursday, October 6, 2011 (Hall 318) Organizer & Chair: Pann-Ghill Suh, D.V.M., Ph.D. (School of Nano-Bioscience and Chemical Engineering, Ulsan National Institute of Science and Technology, Korea) SY06-1 SY06-2 SY06-3 SY06-4 SY06-5

21 Redox Modulation of Pro-Inflammatory and Anti-Inflammatory Symposium 7 Signaling 15:30-18:00, Thursday, October 6, 2011 (Grand Conference Room 401) Organizer & Chair: Young-Joon Surh, Ph.D. (College of Pharmacy, Seoul National University, Korea) SY07-1 è SY07-2 SY07-3 SY07-4 SY07-5

22 Symposium 8 Cancer Biology By the Korean Society for Biochemistry and Molecular Biology 15:30-18:00, Thursday, October 6, 2011 (Hall 307) Organizers & Chairs: Han-Woong Lee, Ph.D. (College of Life Science and Biotechnology, Yonsei University, Korea) Kyung-Hee Chun, Ph.D. (National Cancer Center, Korea) SY08-1 SY08-2 (Short Talk) SY08-3 SY08-4 SY08-5 SY08-6 (Short Talk) SY08-7

23 Symposium 9 Bio-Molecular Imaging 15:30-18:00, Thursday, October 6, 2011 (Hall 308) Organizer & Chair: Jung Joon Min, M.D., Ph.D. (Nuclear Medicine, Chonnam National University Medical School, Korea) SY09-1 SY09-2 SY09-3 SY09-4

24 Symposium 10 O-GlcNAc Biology 15:30-18:00, Thursday, October 6, 2011 (Hall 317) Organizer & Chair: Jin Won Cho, Ph.D. (College of Life Science and Biotechnology, Yonsei University, Korea) SY10-1 SY10-2 SY10-3 SY10-4 SY10-5

25 Symposium 11 Presynaptic Vesicular Traffickings 15:30-18:00, Thursday, October 6, 2011 (Hall 318) Organizer & Chair: Sunghoe Chang, Ph.D. (Seoul National University College of Medicine, Korea) SY11-1 (Ééé SY11-2 ü ü SY11-3 SY11-4

26 Symposium 12 Chromatin Remodeling and Gene Expression 09:00-11:30, Friday, October 7, 2011 (Grand Conference Room 401) Organizers: Eun-Jung Cho, Ph.D. (School of Pharmacy, Sungkyunkwan University, Korea) Daeyoup Lee, Ph.D. (Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Korea) Chairs: Hyockman Kwon, Ph.D. (Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Korea) Hansol Lee, Ph.D. (Department of Biological Science, Inha University, Korea) SY12-1 SY12-2 SY12-3 SY12-4 SY12-5 SY12-6

27 Symposium 13 Mouse Phenogenomics 09:00-11:25, Friday, October 7, 2011 (Grand Conference Room 402) Organizer & Chair: Je Kyung Seong, D.V.M., Ph.D. (College of Veterinary Medicine, Seoul National University, Korea) SY13-1 SY13-2 SY13-3 SY13-4

28 Symposium 14 Molecular and Cellular Mechanisms of Plant Development Plasticity 09:00-11:20, Friday, October 7, 2011 (Hall 307) Organizer: Woo Taek Kim, Ph.D. (College of Life Science and Biotechnology, Yonsei University, Korea) Chairs: Byeong-ha Lee, Ph.D. (Department of Life Sciences, Sogang University, Korea) Jeong Hoe Kim, Ph.D. (College of Natural Sciences, Kyungpook National University, Korea) SY14-1 SY14-2 SY14-3 SY14-4 SY14-5 SY14-6

29 Symposium 15 Bioactive Lipid Signaling in Cancer and Inflammation 09:00-11:30, Friday, October 7, 2011 (Hall 308) Organizer: Jae-Hong Kim, Ph.D. (Division of Life Sciences, Korea University, Korea) Chairs: Jae-Hong Kim, Ph.D. (Division of Life Sciences, Korea University, Korea) Hae Young Chung, Ph.D. (College of Phamacy, Pusan National University, Korea) SY15-1 SY15-2 SY15-3 SY15-4 SY15-5 SY15-6

30 Symposium 16 Criminal DNA Database and Forensic Genetics 09:00-11:30, Friday, October 7, 2011 (Hall 317) Organizer & Chair: Seung Hwan Lee, Ph.D. (DNA Analysis Laboratory, Division of Forensic Science, Supreme Prosecution Service, Korea) SY16-1 ü SY16-2 SY16-3 SY16-4 SY16-5

31 Symposium 17 Structural Biology of Post-Translational Modification Proteins 09:00-11:25, Friday, October 7, 2011 (Hall 318) Organizers & Chairs: Weontae Lee, Ph.D. (College of Life Science and Biotechnology, Yonsei University, Korea) Soo Hyun Eom, Ph.D. (School of Life Sciences, Gwangju Institute of Science and Technology, Korea) SY17-1 SY17-2 SY17-3 SY17-4 SY17-5 SY17-6 (Short Talk)

32 Symposium 18 Autophagy 15:30-18:00, Friday, October 7, 2011 (Grand Conference Room 401) Organizer & Chair: Myung-Shik Lee, M.D., Ph.D. (Sungkyunkwan University School of Medicine, Korea) SY18-1 SY18-2 SY18-3 SY18-4 SY18-5

33 Symposium 19 Stem Cells: Biology and Therapeutic Applications 15:30-18:00, Friday, October 7, 2011 (Grand Conference Room 402) Organizer: Jae Hong Seol, Ph.D. (School of Biological Sciences, Seoul National University, Korea) Chairs: Jae Hong Seol, Ph.D. (School of Biological Sciences, Seoul National University, Korea) Yong-Mahn Han, Ph.D. (Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Korea) SY19-1 SY19-2 SY19-3 SY19-4 SY19-5

34 Symposium 20 Systems Biology for Plants 15:30-18:10, Friday, October 7, 2011 (Hall 307) Organizer & Chair: Ildoo Hwang, Ph.D. (Department of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology, Korea) SY20-1 SY20-2 SY20-3 SY20-4 SY20-5 SY20-6

35 Symposium 21 The Advancement of Innate Immunity: Pattern-Recognition Receptors and Their Actions 15:30-18:10, Friday, October 7, 2011 (Hall 308) Organizers & Chairs: Bok Luel Lee, Ph.D. (College of Phamacy, Pusan National University, Korea) ) Joo Young Lee, Ph.D. (School of Life Sciences, Gwangju Institute of Science and Technology, Korea) SY21-1 SY21-2 SY21-3 SY21-4 SY21-5

36 Symposium 22 Bone and Cartilage Biology 15:30-18:00, Friday, October 7, 2011 (Hall 319) Organizer & Chair: Eun-Jung Jin, Ph.D. (College of Natural Sciences, Department of Biological Sciences, Wonkwang University, Korea) SY22-1 SY22-2 SY22-3 SY22-4 SY22-5 SY22-6

37 Symposium 23 Convergence Sciences and Mucosal Immune System 15:30-18:00, Friday, October 7, 2011 (Hall 318) Organizer & Chair: Sin-Hyeog Im, Ph.D. (School of Life Sciences, Gwangju Institute of Science and Technology, Korea) SY23-1 SY23-2 SY23-3 ö SY23-4

38 연구윤리심포지엄 Research Ethics Symposium (Korean) Research Ethics Symposium 11:30-12:30, Thursday, October 6, 2011 (Hall 307) Organizer & Chair: ES-1 ES-2

39 시 상 Awards

40 초록등록 Abstract Submission

41 우수포스터상응모안내 (Excellent Poster Awards)

42 포스터발표 Poster Presentation

43 포스터제작안내 Guidline for Poster Preparation

44 기기전시회 Exhibition

45

46 기기전시회참가안내

47

48

49 2011 년도한국분자 세포생물학회정기학술대회기기전시참가및초록집광고게재신청서

50 제품설명회 Company Workshop 제품설명회참가신청서

51 출장협조의뢰서

52 교통편안내 Direction

53 주차안내

54 한국분자 세포생물학회 Korean Society for Molecular and Cellular Biology